Skip to main content
OpenTrials
Completed

NCT Number: NCT03582540

Early Versus Delayed Double-guidewire Technique in Difficult Biliary Cannulation. (DFG)

This is a prospective randomized comparative multicentric study. Briefly, we will analyze the technical success, performance and clinical outcomes of early versus delayed double-guidewire technique (DGT) in difficult biliary cannulation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clinique de Bercy, Charenton-le-Pont, France

Loading trial locations.

About this study

This is a prospective study performed in 20 tertiary medical centers in France. We aim to recruit 150 patients from 2016 to 2020. Patients with a native papilla scheduled for ERCP (endoscopic retrograde cholangiopancreatography) are screened for the study. Patients with a difficult biliary cannulation are included in the study if the guidewire is inserted in the pancreatic duct. At that point, patients are randomized in two arms: early versus delayed DGT. The early arm attempts biliary cannulation using the double-guidewire technique immediately and the delayed arm uses the double-guidewire technique only if 10 more minutes of standard cannulation technique does not allow biliary cannulation. The primary outcome is the biliary cannulation rate success. Secondary outcomes are complications rate and performance of the technique in both arms. Follow-up is 30 days.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients 18 years old and more
  • Native papilla
  • Clinical indications of ERCP
  • Difficult biliary cannulation defined by unintentional guidewire insertion into the pancreatic duct before biliary cannulation is successful
  • Informed consent completed by the patient

Exclusion criteria

  • Contraindication to upper gastrointestinal endoscopy
  • ERCP with direct biliary cannulation success
  • ERCP with inability to cannulate the bile duct nor the pancreatic duct
  • Coagulation or hemostasis disorder (TP < 60%, TCA> 40 sec. et plaquettes < 60000/mm3).
  • Patient under active antiaggregant or anticoagulant medication other than aspirin
  • Endoscopic treatment of chronic pancreatitis
  • Pregnancy or breastfeeding
  • ERCP performed by another operator than an investigator
  • Patient's voluntary withdrawal
  • Withdrawal decision by the investigator or sponsor

Treatment and study plan

Double-guidewire cannulation technique

Procedure

With the DGT, a guidewire is first inserted deep into the PD. The cannulation device is then withdrawn, reloaded with a second guidewire, and reinserted through the working channel of the endoscope to cannulate the common bile duct.

Primary outcomes

  1. Biliary cannulation success rate

    Time frame: During the ERCP procedure

    The percentage of biliary cannulation success in both arms.

Secondary outcomes

  1. Immediate morbidity

    Time frame: From the start, until 30 minutes after completion of ERCP

    Any complications (procedure related, clinical or anesthesiological) occurring during the procedure or during the immediate post-intervention period.

  2. Delayed morbidity

    Time frame: 30 minutes after ERCP completion and up to 30 days

    Morbidities occurring more than 30 minutes and up to 1 month after ERCP completion. Special attention will be taken for bowel perforation, gastrointestinal bleeding and acute pancreatitis

  3. procedural time

    Time frame: time from the first guidewire insertion into the pancreatic duct up to the end of cannulation.

    The time taken in minutes between patient randomization (at the first guidewire insertion into the pancreatic duct) and successful biliary cannulation.

Sponsors and collaborators

Lead sponsor

Société Française d'Endoscopie Digestive

Other

Registry information

Official study title

Study Assessing the Interest of the Double-guidewire Technique for Catheterization of the Common Bile Duct.

Acronym: DFG

Important dates

Study start
2016
Primary completion
2019
Study completion
2019
First posted
Jul 11, 2018
Registry last updated
Sep 23, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.